GRI Bio, Inc.

GRI

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001824293

SEC filings (opens in a new tab)

No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding GRI Bio, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of GRI: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	5	6	+1
Shares	1.20M	572.4K	−625.3K (−52.2%)
Value	$5.09M	$887.2K	−$4.20M (−82.6%)

New holders (2)

Institutions that held GRI Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to GRI in Q3 2023
Institution	Shares	Value	% of portfolio
Vanguard Group Inc	18,539	$28.7K	0.00%
Stratos Wealth Partners, LTD.	10,000	$15.5K	0.00%

Sold out (1)

Institutions that held GRI Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of GRI in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
UBS Group AG	899	$3.82K